We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > LIQOSEAL®

News List

Polyganics Achieves CE Mark Certification for LIQOSEAL® b3cnewswire
January 16, 2020
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has obtained CE marking for LIQOSEAL®, its easy-to-use and innovative dural sealant patch ...
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure b3cnewswire
November 10, 2018
The trial, titled ‘ENCASE’, is a single-arm, open-label study, evaluating safety and performance of LIQOSEAL® in reducing CSF leakage following elective cranial surgery. Up to 40 adult patients will be recruited at three sites across the Netherlands and S
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure b3cnewswire
November 10, 2018
The trial, titled ‘ENCASE’, is a single-arm, open-label study, evaluating safety and performance of LIQOSEAL® in reducing CSF leakage following elective cranial surgery. Up to 40 adult patients will be recruited at three sites across the Netherlands and S